Inventor

John F. Burd

Inventor
San Diego, CA, US

Overview

40→
Patents
1980–2021
Patent span
Physics
Primary field (CPC G)

Patents· 40 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

G01Nprimary
G01NInvestigating or analysing materials by determining their chemical or physical properties24%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests16%
A61BDiagnosis9%
A61KPreparations for medical, dental or toiletry purposes8%
Y10TTechnical subjects covered by former us classification7%
C07DHeterocyclic compounds6%
C07HSugars6%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms6%
A23LFoods, foodstuffs or non-alcoholic beverages, not otherwise provided for5%
C07KPeptides4%
PatentTitleYear
11,045,495Method of improving beta cell function using a supplement202110,980,834Prevention of protein glycation using lysine supplements202110,695,368Prevention of protein glycation using lysine supplements202010,653,720Prevention of protein glycation using lysine/zinc supplements202010,656,166Inhibiting chronic blood and nephrological disorders using lysine-based supplements202010,610,544Insulin resistance and beta cell function using lysine-based supplements202010,466,256Inhibiting chronic blood and nephrological disorders using lysine-based supplements20198,483,793'Dual electrode system for a continuous analyte sensor'20137,896,809'Dual electrode system for a continuous analyte sensor'20117,761,130'Dual electrode system for a continuous analyte sensor'20107,693,560'Dual electrode system for a continuous analyte sensor'20106,975,892'Methods for non-invasive analyte measurement from the conjunctiva'20056,968,222'Methods and device for non-invasive analyte measurement'20056,958,039'Method and instruments for non-invasive analyte measurement'20056,958,129'Combined assay for current glucose level and intermediate or long-term glycemic control'20056,670,192'Apparatus for combined assay for current glucose level and intermediate or long-term glycemic control'20036,627,153'Integrated assay for organ function, drugs and/or one or more metabolites'20036,558,321'Systems and methods for remote monitoring and modulation of medical devices'20036,456,066'Eddy current pipeline inspection device and method'20026,027,692'Apparatus for combined assay for current glucose level and intermediate or long-term glycemic control'20005,939,331'Red blood cell separation means for specific binding assays'19995,885,839'Methods of determining initiation and variable end points for measuring a chemical reaction'19995,695,949'Combined assay for current glucose level and intermediate or long-term glycemic control'19975,639,672'Electrochemical determination of fructosamine'19975,470,752'Multi-layer devices and methods of assaying for fructosamine'19955,082,768'Attenuator to suppress extraneous light in luminescent specific-binding assays'19924,743,541'Luminescent substrate preparation and its use in specific binding assays'19884,650,771'Immunogens, antibodies, labeled conjugates, and related derivatives for lidocaine and analogs thereof'19874,608,336'#3B theophylline immunoassay employing 9-theophylline reagents'19864,533,493'Theophylline immunogens, antibodies, labeled conjugates, and related derivatives'19854,460,772'6-[N-(.omega.-Carboxyalkyl)amino]-1,3-dimethyl-5-formamidouracils'19844,404,366'Beta-galactosyl-umbelliferone-labeled hapten conjugates'19834,345,350'Pipeline cleaning equipment'19824,331,590'.beta.-Galactosyl-umbelliferone-labeled protein and polypeptide conjugates'19824,318,981'Homogeneous specific binding assay employing an intramolecularly modulated photogenic enzyme substrate label'19824,292,425'.beta.Galactosyl-umbelliferone valproic acid conjugates'19814,279,992'Specific binding assay employing an enzyme-cleavable substrate as label'19814,273,715'N-(hydroxyalkyl)-7-hydroxycoumarin-3-carboxamides'19814,261,974'Valproic acid immunogen conjugates and antibodies thereto'19814,226,978'.beta.-Galactosyl-umbelliferone-labeled aminoglycoside antibiotics and intermediates in their preparation'1980

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1980–1987Patents assigned to MILES LAB (12)· patent assignee history
1980–1986Based in Elkhart, IN, US· patent location history
1987–1992Based in Mountain View, CA, US· patent location history
1988Based in Sunnyvale, CA, US· patent location history
1995–2000Patents assigned to LXN CORP (5)· patent assignee history
1995–2021Based in San Diego, CA, US· patent location history
2002Based in West Bridgford, GB· patent location history
2003–2013Patents assigned to DEXCOM INC (4)· patent assignee history
2005Patents assigned to OCULIR INC (3)· patent assignee history
2019–2021Patents assigned to LYSULIN INC (6)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
MILES LAB121980–1987
LYSULIN INC62019–2021
LXN CORP51995–2000
DEXCOM INC42003–2013
OCULIR INC32005
Locations
LocationPatentsSpan
San Diego, California, US241995–2021
Elkhart, IN, US111980–1986
Mountain View, California, US21987–1992
West Bridgford, GB12002
Sunnyvale, California, US11988